Centre For Research Excellence In Prostate Cancer Survivorship (CRE-PCS)
Funder
National Health and Medical Research Council
Funding Amount
$2,498,842.00
Summary
The Centre for Research Excellence in Prostate Cancer Survivorship will 1) develop, evaluate and translate responsive, equitable and accessible survivorship interventions for men with prostate cancer and their partners and families in high need areas 2) support evidence-based policy and practice in prostate cancer survivorship care 3) train and equip the workforce and its leaders to ensure translation and sustainably improve the underpinning health care and other relevant systems.
Over 10,000 persons per year in Australia are diagnosed with a blood cancer, accounting for 11% of cancer deaths. Stem cell transplantation remains curative therapy for these diseases but is limited by cancer relapse and an immune-mediated process known as graft-versus-host disease (GVHD) which account for death of up to 50% of patients. This CRE will integrate centres from Australia and the USA to coordinate new treatments in transplant and cell therapy to improve blood cancer outcomes.